Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
2015 ◽
Vol 33
(15_suppl)
◽
pp. 108-108
◽
2011 ◽
2015 ◽
2018 ◽
2019 ◽
2011 ◽
Vol 132
(3)
◽
pp. 843-851
◽